{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:50:29Z","timestamp":1790128229680,"version":"4.0.1"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Nuclear Medicine"],"published-print":{"date-parts":[[1995,5]]},"DOI":"10.1097\/00003072-199505000-00004","type":"journal-article","created":{"date-parts":[[2006,10,9]],"date-time":"2006-10-09T06:37:23Z","timestamp":1160375843000},"page":"398-402","source":"Crossref","is-referenced-by-count":14,"title":["A New Thrombus Imaging Agent Human Recombinant Fibrin Binding Domain Labeled With In-111"],"prefix":"10.1097","volume":"20","author":[{"given":"LEONARD","family":"ROSENTHALL","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JACQUES","family":"LECLERC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003072-199505000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:51:23Z","timestamp":1785862283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003072-199505000-00004"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":0,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1097\/00003072-199505000-00004","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[1995,5]]}}}